Published in J Urol on June 19, 2010
Neural control of the lower urinary tract. Compr Physiol (2015) 1.11
Salutary effect of gastric pentadecapeptide BPC 157 in two different stress urinary incontinence models in female rats. Med Sci Monit Basic Res (2013) 0.77
A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. Epidemiology of Incontinence in the County of Nord-Trøndelag. J Clin Epidemiol (2000) 6.09
Prevalence of urinary incontinence and other urological symptoms in the noninstitutionalized elderly. J Urol (1986) 2.43
Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann Intern Med (2008) 2.22
Duloxetine versus placebo in the treatment of stress urinary incontinence. Am J Obstet Gynecol (2002) 2.16
National Institutes of Health state-of-the-science conference statement: prevention of fecal and urinary incontinence in adults. Ann Intern Med (2008) 2.10
Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat. J Pharmacol Exp Ther (1995) 1.77
Use and costs of incontinence pads in female study volunteers. Continence Program for Women Research Group. J Wound Ostomy Continence Nurs (1999) 1.74
Epidemiology and natural history of urinary incontinence in women. Urology (2003) 1.66
Effect of simulated birth trauma on the urinary continence mechanism in the rat. Urology (1998) 1.59
Economic costs of urinary incontinence in community-dwelling Australian women. Med J Aust (2001) 1.57
Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence. J Urol (2003) 1.56
Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. Eur Neuropsychopharmacol (2004) 1.40
Prolapse and incontinence surgery in older women. J Urol (2008) 1.39
Urethral closure mechanisms under sneeze-induced stress condition in rats: a new animal model for evaluation of stress urinary incontinence. Am J Physiol Regul Integr Comp Physiol (2003) 1.32
Tension-Free vaginal tape (TVT) in women with recurrent stress urinary incontinence--a long-term follow up. Int Urogynecol J Pelvic Floor Dysfunct (2001) 1.26
Effect of duloxetine, a norepinephrine and serotonin reuptake inhibitor, on sneeze-induced urethral continence reflex in rats. Am J Physiol Renal Physiol (2008) 1.20
Role of noradrenergic pathways in sneeze-induced urethral continence reflex in rats. Am J Physiol Renal Physiol (2006) 1.18
The cost of clinically significant urinary storage symptoms for community dwelling adults in the UK. BJU Int (2004) 1.17
Pharmacological analysis of the noradrenergic control of central sympathetic and somatic reflexes controlling the lower urinary tract in the anesthetized cat. J Pharmacol Exp Ther (1995) 1.15
The impact of urinary incontinence on the quality of life of women. World J Urol (1999) 1.12
International group seeks to dispel incontinence "taboo". JAMA (1998) 1.07
Effect of postpartum pelvic floor muscle training in prevention and treatment of urinary incontinence: a one-year follow up. BJOG (2000) 1.02
Functional analysis of active urethral closure mechanisms under sneeze induced stress condition in a rat model of birth trauma. J Urol (2006) 1.01
Tension-free vaginal tape in the elderly: is it a safe procedure? Urology (2005) 0.98
Tension-free vaginal tape (TVT) for the treatment of occult stress urinary incontinence in women undergoing prolapse repair: a prospective study of 100 consecutive cases. Neurourol Urodyn (2004) 0.95
A retrospective pooled analysis of duloxetine safety in 23,983 subjects. Curr Med Res Opin (2007) 0.93
Comparison of ligand binding affinities at human I1-imidazoline binding sites and the high affinity state of alpha-2 adrenoceptor subtypes. J Pharmacol Exp Ther (1996) 0.87
Role of alpha2-adrenoceptors and glutamate mechanisms in the external urethral sphincter continence reflex in rats. J Urol (2009) 0.85
Duloxetine: a dual reuptake inhibitor. Ann Pharmacother (2004) 0.83
Duloxetine as a treatment for stress incontinence--where are we now? Int Urogynecol J Pelvic Floor Dysfunct (2007) 0.78
The neural control of micturition. Nat Rev Neurosci (2008) 4.19
Unroofed coronary sinus syndrome: diagnosis, classification, and surgical treatment. J Thorac Cardiovasc Surg (2003) 2.50
Survival and prognostic classification of patients with metastatic renal cell carcinoma of bone. Eur Urol (2006) 2.34
Intravesical botulinum toxin A administration inhibits COX-2 and EP4 expression and suppresses bladder hyperactivity in cyclophosphamide-induced cystitis in rats. Eur Urol (2008) 2.24
Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder. BJU Int (2004) 2.11
Inhibition of mTORC2 but not mTORC1 up-regulates E-cadherin expression and inhibits cell motility by blocking HIF-2α expression in human renal cell carcinoma. J Urol (2012) 2.08
Mechanisms of disease: involvement of the urothelium in bladder dysfunction. Nat Clin Pract Urol (2007) 2.06
Urologic complications of diabetes. Diabetes Care (2005) 2.03
Abnormal dimercapto-succinic acid scan is a predictive factor of breakthrough urinary tract infection in children with primary vesicoureteral reflux. J Urol (2009) 2.01
Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection. Eur Urol (2008) 1.96
Current use of the artificial urinary sphincter and its long-term durability: a nationwide survey in Japan. Int J Urol (2009) 1.96
Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action. Neurourol Urodyn (2011) 1.93
Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid naïve patients with active ulcerative colitis: a prospective uncontrolled study. Dig Dis Sci (2004) 1.92
Botulinum toxin type A improves benign prostatic hyperplasia symptoms in patients with small prostates. Urology (2005) 1.81
Impact of multimodal treatment on survival in patients with metastatic urothelial cancer. Eur Urol (2007) 1.77
Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Urology (2005) 1.77
Mechanisms underlying the recovery of lower urinary tract function following spinal cord injury. Prog Brain Res (2006) 1.74
An artificial somatic-central nervous system-autonomic reflex pathway for controllable micturition after spinal cord injury: preliminary results in 15 patients. J Urol (2003) 1.73
Inhibition of bladder overactivity by a combination of tibial neuromodulation and tramadol treatment in cats. Am J Physiol Renal Physiol (2012) 1.65
Pudendal-to-bladder reflex in chronic spinal-cord-injured cats. Exp Neurol (2005) 1.63
Novel action of botulinum toxin on the stromal and epithelial components of the prostate gland. J Urol (2006) 1.62
Pannexin 1 channels mediate the release of ATP into the lumen of the rat urinary bladder. J Physiol (2015) 1.59
Beta-adrenoceptor agonists stimulate endothelial nitric oxide synthase in rat urinary bladder urothelial cells. J Neurosci (2002) 1.58
Vascular endothelial growth factor in children with congenital heart disease. Ann Thorac Surg (2003) 1.57
An HSV vector system for selection of ligand-gated ion channel modulators. Nat Methods (2007) 1.57
Recent advances in understanding the biology of diabetes-associated bladder complications and novel therapy. BJU Int (2005) 1.56
How sacral nerve stimulation neuromodulation works. Urol Clin North Am (2005) 1.55
The role of capsaicin-sensitive afferent fibers in the lower urinary tract dysfunction induced by chronic spinal cord injury in rats. Exp Neurol (2004) 1.54
Future direction in pharmacotherapy for non-neurogenic male lower urinary tract symptoms. Eur Urol (2013) 1.54
The role of lymph-node dissection in the treatment of upper urinary tract cancer: a multi-institutional study. BJU Int (2008) 1.53
Nerve growth factor level in the prostatic fluid of patients with chronic prostatitis/chronic pelvic pain syndrome is correlated with symptom severity and response to treatment. BJU Int (2010) 1.52
Effects of intrathecal injection of tamsulosin and naftopidil, alpha-1A and -1D adrenergic receptor antagonists, on bladder activity in rats. Neurosci Lett (2002) 1.51
Block of external urethral sphincter contraction by high frequency electrical stimulation of pudendal nerve. J Urol (2004) 1.51
Cytogenetic abnormalities of tumor-associated endothelial cells in human malignant tumors. Am J Pathol (2009) 1.51
Association of overactive bladder and C-reactive protein levels. Results from the Boston Area Community Health (BACH) Survey. BJU Int (2011) 1.50
Bladder overactivity and hyperexcitability of bladder afferent neurons after intrathecal delivery of nerve growth factor in rats. J Neurosci (2006) 1.48
Pathophysiology of urinary incontinence in murine models. Int J Urol (2012) 1.48
Changes in dopaminergic and glutamatergic excitatory mechanisms of micturition reflex after middle cerebral artery occlusion in conscious rats. Exp Neurol (2002) 1.48
Bladder Adelta afferent nerve activity in normal cats and cats with feline interstitial cystitis. J Urol (2005) 1.48
Ventricular septal dysfunction after surgical closure of multiple ventricular septal defects. Ann Thorac Surg (2013) 1.47
Effect of (+/-)-epibatidine, a nicotinic agonist, on the central pathways controlling voiding function in the rat. Am J Physiol Regul Integr Comp Physiol (2003) 1.47
Appropriate additional pulmonary blood flow at the bidirectional Glenn procedure is useful for completion of total cavopulmonary connection. Ann Thorac Surg (2005) 1.47
Current and future pharmacological treatment for overactive bladder. J Urol (2002) 1.47
Transabdominal ultrasonography of detrusor wall thickness in women with overactive bladder. BJU Int (2009) 1.46
Effect of botulinum toxin A on urothelial-release of ATP and expression of SNARE targets within the urothelium. Neurourol Urodyn (2013) 1.46
Emerging role of botulinum toxin in the treatment of neurogenic and non-neurogenic voiding dysfunction. Curr Urol Rep (2002) 1.44
Bladder inhibition or voiding induced by pudendal nerve stimulation in chronic spinal cord injured cats. Neurourol Urodyn (2007) 1.43
Pharmacokinetics, metabolism, and saliva output during transdermal and extended-release oral oxybutynin administration in healthy subjects. Mayo Clin Proc (2003) 1.43
RENAL nephrometry score is a predictive factor for the annual growth rate of renal mass. Int J Urol (2014) 1.43
Influence of baseline renal function and dose reduction of nephrotoxic chemotherapeutic agents on the outcome of metastatic urothelial carcinoma: a retrospective study. Int J Urol (2011) 1.42
Expression of functional nicotinic acetylcholine receptors in rat urinary bladder epithelial cells. Am J Physiol Renal Physiol (2005) 1.42
Afferent nerve regulation of bladder function in health and disease. Handb Exp Pharmacol (2009) 1.42
Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study. Int Urol Nephrol (2009) 1.41
Immunoneutralization of nerve growth factor in lumbosacral spinal cord reduces bladder hyperreflexia in spinal cord injured rats. J Urol (2002) 1.41
Simulation analysis of conduction block in unmyelinated axons induced by high-frequency biphasic electrical currents. IEEE Trans Biomed Eng (2005) 1.40
Long-term outcome of vaginoplasty with the bilateral labioscrotal flap. J Urol (2009) 1.40
Sustained beneficial effects of intraprostatic botulinum toxin type A on lower urinary tract symptoms and quality of life in men with benign prostatic hyperplasia. BJU Int (2006) 1.40
An infected pseudoaneurysm following a modified Blalock-Taussig shunt. Interact Cardiovasc Thorac Surg (2008) 1.39
Inhibitory role of the spinal galanin system in the control of micturition. Urology (2013) 1.39
Differential role of opioid receptors in tibial nerve inhibition of nociceptive and nonnociceptive bladder reflexes in cats. Am J Physiol Renal Physiol (2012) 1.38
Cool (TRPM8) and hot (TRPV1) receptors in the bladder and male genital tract. J Urol (2004) 1.36
Simulation of nerve block by high-frequency sinusoidal electrical current based on the Hodgkin-Huxley model. IEEE Trans Neural Syst Rehabil Eng (2005) 1.33
External urethral sphincter activity in a rat model of pudendal nerve injury. Neurourol Urodyn (2006) 1.32
Urethral closure mechanisms under sneeze-induced stress condition in rats: a new animal model for evaluation of stress urinary incontinence. Am J Physiol Regul Integr Comp Physiol (2003) 1.32
Transmembrane interaction mediates complex formation between peptidase homologues and Kv4 channels. Mol Cell Neurosci (2005) 1.30
Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy? J Clin Apher (2005) 1.30
The role of bladder-to-urethral reflexes in urinary continence mechanisms in rats. Am J Physiol Renal Physiol (2004) 1.29
Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment. BJU Int (2009) 1.28
Non-neuronal acetylcholine and urinary bladder urothelium. Life Sci (2007) 1.27
Activation of muscarinic receptors in rat bladder sensory pathways alters reflex bladder activity. J Neurosci (2008) 1.26
Expression and function of bradykinin B1 and B2 receptors in normal and inflamed rat urinary bladder urothelium. J Physiol (2004) 1.26
Rehabilitation and medical management of the adult with spina bifida. Am J Phys Med Rehabil (2008) 1.26
Changes in afferent activity after spinal cord injury. Neurourol Urodyn (2010) 1.26
Nerve growth factor in bladder dysfunction: contributing factor, biomarker, and therapeutic target. Neurourol Urodyn (2011) 1.25
Therapeutic receptor targets for lower urinary tract dysfunction. Naunyn Schmiedebergs Arch Pharmacol (2007) 1.25
Inhibitory and excitatory perigenital-to-bladder spinal reflexes in the cat. Am J Physiol Renal Physiol (2007) 1.25
Management of renal angiomyolipomas associated with tuberous sclerosis complex. J Urol (2004) 1.25
Medical management of recurrent aggressive angiomyxoma with gonadotropin-releasing hormone agonist. Int J Urol (2004) 1.25
An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment. Am J Gastroenterol (2009) 1.24
Suppression of detrusor-sphincter dyssynergia by immunoneutralization of nerve growth factor in lumbosacral spinal cord in spinal cord injured rats. J Urol (2004) 1.24